Answers are grounded in this paper and cite their sources.
Review reports advances in molecular characterization and targeted immunotherapies for advanced non-small-cell lung cancer, indicating progress toward personalized clinical oncology.
Smoking cessation has reduced the incidence of lung cancer. The authors of this review discuss recent progress in diagnostic and treatment approaches, including molecular characterization to determine the likelihood of a response to targeted agents and immunotherapies.
No takes yet. Share an insight, caveat, or question.
Reck et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: